Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 12, 2013, Pages 1365-1371

  Nakamura, Ryoichi ^a   Atsuta, Naoki ^a   Watanabe, Hazuki ^a   Hirakawa, Akihiro ^a   Watanabe, Hirohisa ^a   Ito, Mizuki ^a   Senda, Jo ^a   Katsuno, Masahisa ^a   Tanaka, Fumiaki ^b   Izumi, Yuishin ^c   Morita, Mitsuya ^d   Ogaki, Kotaro ^e   Taniguchi, Akira ^f   Aiba, Ikuko ^g   Mizoguchi, Koichi ^h   Okamoto, Koichi ⁱ   Hasegawa, Kazuko ^j   Aoki, Masashi ^k   Kawata, Akihiro ^l   Abe, Koji ^m   Oda, Masaya ⁿ   Konagaya, Masaaki ^o   Imai, Takashi ^p   Nakagawa, Masanori ^q   Tsuji, Shoji ^r   Kaji, Ryuji ^c   Nakano, Imaharu ^d   Sobue, Gen ^a   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Meito ku   (Japan)

^h SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

ⁱ GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^k TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^m OKAYAMA UNIVERSITY   (Japan)

ⁿ Vihara Hananosato Hospital   (Japan)

^o SUZUKA NATIONAL HOSPITAL   (Japan)

^p MIYAGI NATIONAL HOSPITAL   (Japan)

^q KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^r UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADL DISABILITY; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANKLE; ARM MOVEMENT; ARTICLE; ARTIFICIAL VENTILATION; BODY MOVEMENT; BULBAR PARALYSIS; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; DISEASE MARKER; DYSPHAGIA; EXTENSOR MUSCLE; FEMALE; FLEXOR MUSCLE; HIP; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; NECK MUSCLE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SHOULDER; SPEECH DISORDER; SURVIVAL; WALKING DIFFICULTY; WRIST;

EID: 84888039014     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306020     Document Type: Article

References (44)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-700.
2. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-19.
3. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:1316-22.
4. Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55.
5. Chio A, Calvo A, Moglia C, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740-6.
6. del Aguila MA, Longstreth WT Jr, McGuire V, et al. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-19.
7. Magnus T, Beck M, Giess R, et al. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709-14.
8. Chio A, Mora G, Leone M, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002;59:99-103.
9. Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties. Neurology 1990;40:600-4.
10. Millul A, Beghi E, Logroscino G, et al. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005;25:114-19.
11. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998;50:66-72.
12. Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 2006;77:390 -2.
13. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006;253:1428-36.
14. Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64:38-43.
15. Armon C, Graves MC, Moses D, et al. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000;23:874-82.
16. Armon C, Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998;160( Suppl 1): S37-41.
17. Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265- 7.
18. Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310-23.
19. Medical Research Council. Aids to the examination of the peripheral nervous system. London: Her Majesty's Stationery Office, 1976.
20. Campbell WW. Dejong's Neurologic Examination. Philadelphia, USA: Lippincott Williams & Wilkins, 2005.
21. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
22. Ohashi Y, Tashiro K, Itoyama Y, et al. Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version. No To Shinkei 2001;53:346-55.
23. Atsuta N, Watanabe H, Ito M, et al. Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study. Brain Nerve 2011;63:491-6.
24. Kasarskis EJ, Dempsey-Hall L, Thompson MM, et al. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:50-4.
25. Kaufmann P, Levy G, Montes J, et al. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler 2007;8:42- 6.
26. Mannino M, Cellura E, Grimaldi G, et al. Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol 2007;14:79-84.
27. Chancellor AM, Slattery JM, Fraser H, et al. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993;240:339-46.
28. Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012;3:CD001447.
29. Brendler SJ. Human cervical myotomes-functional anatomy studied at operation. J Neurosurg 1968;28:105-11.
30. Parent A. Carpenter's human neuroanatomy. Quebec, Canada: Williams & Wilkins, 1996.
31. Pinto S, de Carvalho M. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis. Muscle Nerve 2008;38:1312-17.
32. Pinto S, Pinto A, de Carvalho M. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis. Clin Neurophysiol 2012;123:2454-9.
33. Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805-11.
34. Fujimura-Kiyono C, Kimura F, Ishida S, et al. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82:1244 -9.
35. Kanouchi T, Ohkubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J Neurol Neurosurg Psychiatry 2012;83:739-45.
36. Brettschneider J, Tredici KD, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol Published Online First: 20 May 2013. doi:10.1002/ana.23937.
37. Kavanagh J, Barrett R, Morrison S. The role of the neck and trunk in facilitating head stability during walking. Exp Brain Res 2006;172:454-63.
38. Ballesteros ML, Buchthal F, Rosenfalck P. The pattern of muscular activity during the arm swing of natural walking. Acta Physiol Scand 1965;63:296 -310.
39. Richter RR, VanSant AF, Newton RA. Description of adult rolling movements and hypothesis of developmental sequences. Phys Ther 1989;69:63 -71.
40. Cudkowicz ME, Katz J, Moore DH, et al. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:259 -65.
41. Sorenson EJ. What is next in ALS clinical trials? Neurology 2007;69:719-20.
42. Gourie-Devi M, Nalini A, Sandhya S. Early or late appearance of "dropped head syndrome" in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:683-6.
43. Uemura M, Kosaka T, Shimohata T, et al. et al. Dropped head syndrome in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degeneration 2013;14:232-3.
44. Katz JS, Wolfe GI, Burns DK, et al. Isolated neck extensor myopathy: a common cause of dropped head syndrome. Neurology 1996;46:917-21.